B
BioStem Technologies
BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies
About BioStem Technologies
BioStem Technologies is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care applications.
The company's business model is centered around the development and commercialization of regenerative therapies derived from perinatal tissues. BioStem Technologies operates in the advanced wound care market, a sector of the broader healthcare industry. Its product portfolio includes brands such as RHEO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC, which are designed to provide solutions for complex wounds.
The company serves a range of clients within the healthcare system, including hospitals, clinics, and other healthcare facilities that require advanced wound care treatments. As a publicly traded entity on the OTC markets (BSEM), BioStem Technologies is also focused on creating value for its shareholders through the advancement of its product pipeline and commercial activities.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2006
- Headquarters
- Pompano Beach, United States
- Listing
- IPO 2008
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
16 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioStem Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioStem Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.